X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/01/04/2803801/0/en/Kynexis-Announces-Initiation-of-First-in-Human-Phase-1-Study-of-KYN-5356-a-Potential-Treatment-for-Cognitive-Impairment-Associated-with-Schizophrenia.html